Preparation and cyclodextrin assisted dissolution rate enhancement of itraconazolium dinitrate salt

被引:10
作者
Kumar, Neeraj [1 ]
Shishu [1 ]
Bansal, Gulshan [2 ]
Kumar, Sandeep [3 ]
Jana, Asim Kumar [3 ]
机构
[1] Panjab Univ, UIPS, UGC Ctr Adv Study, Chandigarh 160014, India
[2] Punjabi Univ, Dept Pharmaceut Sci & Drug Res, Patiala, Punjab, India
[3] Dr BR Ambedkar Natl Inst Technol, Dept Biotechnol, Jalandhar, Punjab, India
关键词
Acid/base; Solubility; BCS class II; antifungal; dissolution; SOLID DISPERSIONS; DRUG; HYDROCHLORIDE; NANOPARTICLES; SOLUBILITY; COCRYSTALS;
D O I
10.3109/03639045.2012.681382
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The poor solubility of itraconazole (ITR) results in its variable oral absorption and bioavailability and has also proven to be a major setback in developing an efficient oral delivery system. To improve its solubility and dissolution profile, itraconazolium dinitrate salt (ITRDNT) was prepared and characterized using various spectral and thermal techniques. The morphology of the salt was studied using optical and scanning electron microscopy (SEM). Broth microdilution assay demonstrated antifungal efficacy of ITRDNT similar to ITR against four different fungal strains namely, Asparagillus fumigatus, Microsporum canis, Microsporum gypsum and Trichophyton rubrum. The salt exhibited better solubility profile than ITR in water and a number of pharmaceutical solvents. Dissolution studies revealed the total amount of drug released from ITRDNT in 3 h was four times greater than that of ITR. To further improve dissolution characteristics, the physical mixtures of ITR and ITRDNT with two cyclodextrins, beta-cyclodextrin (beta-CD) and HP-beta-cyclodextrin (HP-beta-CD) were prepared and their molar ratios were optimized. It was observed that about 75% of drug was released in 30 min from 1:3 molar ratio of ITRDNT and HP-beta-CD physical mixture, which was distinctly higher than ITR commercial capsules (70%). Owing to its facile and economical preparation and substantially better in vitro release profile, the ITRDNT and its CD physical mixtures could be better and cost effective alternatives to ITR and commercial ITR capsules.
引用
收藏
页码:342 / 351
页数:10
相关论文
共 38 条
  • [1] Intravenous itraconazole emulsions produced by SolEmuls technology
    Akkar, A
    Müller, RH
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2003, 56 (01) : 29 - 36
  • [2] A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY
    AMIDON, GL
    LENNERNAS, H
    SHAH, VP
    CRISON, JR
    [J]. PHARMACEUTICAL RESEARCH, 1995, 12 (03) : 413 - 420
  • [3] Quality control limits for broth microdilution susceptibility tests of ten antifungal agents
    Barry, AL
    Pfaller, MA
    Brown, SD
    Espinel-Ingroff, A
    Ghannoum, MA
    Knapp, C
    Rennie, RP
    Rex, JH
    Rinaldi, MG
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (09) : 3457 - 3459
  • [4] Microbiological assay for terbinafine hydrochloride in tablets and creams
    Cardoso, SG
    Schapoval, EES
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 203 (1-2) : 109 - 113
  • [5] Cyclodextrins in drug delivery: An updated review
    Challa, R
    Ahuja, A
    Ali, J
    Khar, RK
    [J]. AAPS PHARMSCITECH, 2005, 6 (02)
  • [6] Development and evaluation of novel itraconazole-loaded intravenous nanoparticles
    Chen, Wei
    Gu, Bing
    Wang, Hao
    Pan, Jun
    Lu, Weiyue
    Hou, Huimin
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 362 (1-2) : 133 - 140
  • [7] Investigation of dissolution enhancement of itraconazole by solid dispersion in superdisintegrants
    Chowdary, KPR
    Rao, SS
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2000, 26 (11) : 1207 - 1211
  • [8] Gilis P.M.V., 1997, US Patent, Patent No. [5,633,015, 5633015]
  • [9] Itraconazole formation using supercritical carbon dioxide
    Hassan, A
    Tang, YM
    Ayres, JW
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2004, 30 (10) : 1029 - 1035
  • [10] A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption
    Hong, JY
    Kim, JK
    Song, YK
    Park, JS
    Kim, CK
    [J]. JOURNAL OF CONTROLLED RELEASE, 2006, 110 (02) : 332 - 338